CURRENT STATUS OF THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引：3
|
作者：
LANE, HC
机构：
[1] National Institutes of Health, Bethesda, MD
来源：
CURRENT OPINION IN IMMUNOLOGY | 1992年 / 4卷 / 04期
关键词：
D O I：
10.1016/S0952-7915(06)80044-0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
The past year has seen refinement in our ability to delay the progression of human immunodeficiency virus type 1 infection through the use of nucleoside analogues, singly or in combination. Progress has also been made in our ability to detect drug-resistant isolates of human immunodeficiency virus type 1 and to begin to put the laboratory observations of resistance into a clinical context.
引用
收藏
页码：486 / 489
页数：4
相关论文
共 50 条
  • [31] CIRCULARIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 DNA INVITRO
    FARNET, CM
    HASELTINE, WA
    JOURNAL OF VIROLOGY, 1991, 65 (12) : 6942 - 6952
  • [32] MALIGNANCIES IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    ARICO, M
    CASELLI, D
    DARGENIO, P
    DELMISTRO, AR
    DEMARTINO, M
    LIVADIOTTI, S
    SANTORO, N
    TERRAGNA, A
    CANCER, 1991, 68 (11) : 2473 - 2477
  • [33] HYDROXYCHLOROQUINE TREATMENT OF PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    SPERBER, K
    LOUIE, M
    KRAUS, T
    PRONER, J
    SAPIRA, E
    LIN, S
    STECHER, V
    MAYER, L
    CLINICAL THERAPEUTICS, 1995, 17 (04) : 622 - 636
  • [34] THE TAT GENE AND PROTEIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CAPUTO, A
    GROSSI, MP
    ROSSI, C
    CAMPIONI, D
    BALBONI, PG
    CORALLINI, A
    BARBANTIBRODANO, G
    MICROBIOLOGICA, 1995, 18 (01): : 87 - 110
  • [35] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF NEURAL XENOGRAFTS
    CVETKOVICH, TA
    LAZAR, E
    BLUMBERG, BM
    SAITO, Y
    ESKIN, TA
    REICHMAN, R
    BARAM, DA
    DELCERRO, C
    GENDELMAN, HE
    DELCERRO, M
    EPSTEIN, LG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 5162 - 5166
  • [36] ACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY OXIDATIVE STRESS
    LEGRANDPOELS, S
    VAIRA, D
    PINCEMAIL, J
    VANDEVORST, A
    PIETTE, J
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (12) : 1389 - 1397
  • [37] RNA PACKAGING SIGNAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    HAYASHI, T
    SHIODA, T
    IWAKURA, Y
    SHIBUTA, H
    VIROLOGY, 1992, 188 (02) : 590 - 599
  • [38] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INTEGRASE MUTANTS
    ANSARILARI, MA
    DONEHOWER, LA
    GIBBS, RA
    VIROLOGY, 1995, 211 (01) : 332 - 335
  • [39] THE EFFECT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ON THE INFECTIOUSNESS OF TUBERCULOSIS
    NUNN, P
    MUNGAI, M
    NYAMWAYA, J
    GICHEHA, C
    BRINDLE, RJ
    DUNN, DT
    GITHUI, W
    WERE, JO
    MCADAM, KPWJ
    TUBERCLE AND LUNG DISEASE, 1994, 75 (01): : 25 - 32
  • [40] OLTIPRAZ, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
    PROCHASKA, HJ
    YEH, Y
    BARON, P
    POLSKY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) : 3953 - 3957
12345